These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33842336)

  • 1. LncRNA SNHG19 Promotes the Development of Non-Small Cell Lung Cancer
    Zhao GY; Ning ZF; Wang R
    Front Oncol; 2021; 11():630241. PubMed ID: 33842336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SNHG7 Contributes to the Progression of Non-Small-Cell Lung Cancer via the SNHG7/miR-181a-5p/E2F7 Axis.
    Wang L; Zhang L; Wang L
    Cancer Manag Res; 2020; 12():3211-3222. PubMed ID: 32440218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA DLEU2 promotes the progression of esophageal cancer through miR-30e-5p/E2F7 axis.
    Lu T; Wang R; Cai H; Cui Y
    Biomed Pharmacother; 2020 Mar; 123():109650. PubMed ID: 31884338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway.
    Wang C; Li S; Xu J; Niu W; Li S
    Br J Biomed Sci; 2019 Jan; 76(1):17-23. PubMed ID: 30203720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circ_SATB2 Attenuates the Anti-Tumor Role of Celastrol in Non-Small-Cell Lung Carcinoma Through Targeting miR-33a-5p/E2F7 Axis.
    Liu P; Wang M; Tang W; Li G; Gong N
    Onco Targets Ther; 2020; 13():11899-11912. PubMed ID: 33239891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway.
    He Y; Jiang X; Duan L; Xiong Q; Yuan Y; Liu P; Jiang L; Shen Q; Zhao S; Yang C; Chen Y
    Mol Cancer; 2021 Dec; 20(1):156. PubMed ID: 34856993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
    Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X
    Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circ-CCS is identified as a cancer-promoting circRNA in lung cancer partly by regulating the miR-383/E2F7 axis.
    Yuan Y; Zhou X; Kang Y; Kuang H; Peng Q; Zhang B; Liu X; Zhang M
    Life Sci; 2021 Feb; 267():118955. PubMed ID: 33359669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of Circular RNA Hsa_circ_0109320 Attenuates Non-Small Cell Lung Cancer Progression via MiR-595/E2F7 Axis.
    Bai Q; Li L; Chen F; Zhu J; Cao L; Yang Y; Zhong F
    Med Sci Monit; 2020 Jun; 26():e921200. PubMed ID: 32508344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
    Li X; Zheng H
    Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
    Qiu HB; Yang K; Yu HY; Liu M
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC00941 Promotes Progression of Non-Small Cell Lung Cancer by Sponging miR-877-3p to Regulate VEGFA Expression.
    Ren MH; Chen S; Wang LG; Rui WX; Li P
    Front Oncol; 2021; 11():650037. PubMed ID: 33869051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA SNHG12 regulates the miR-101-3p/CUL4B axis to mediate the proliferation, migration and invasion of non-small cell lung cancer.
    Xie FW; Liu JC
    Kaohsiung J Med Sci; 2021 Aug; 37(8):664-674. PubMed ID: 34002487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long non-coding RNA PVT1/miR-145-5p/ITGB8 axis regulates cell proliferation, apoptosis, migration and invasion in non-small cell lung cancer cells.
    Wei CM; Zhao XF; Qiu HB; Ming Z; Liu K; Yan J
    Neoplasma; 2020 Jul; 67(4):802-812. PubMed ID: 32202906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA MEG8 promotes NSCLC progression by modulating the miR-15a-5p-miR-15b-5p/PSAT1 axis.
    Guo K; Qi D; Huang B
    Cancer Cell Int; 2021 Feb; 21(1):84. PubMed ID: 33526036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA MALAT1 regulates proliferation, apoptosis, migration and invasion via miR-374b-5p/SRSF7 axis in non-small cell lung cancer.
    Song J; Su ZZ; Shen QM
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1853-1862. PubMed ID: 32141554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA WT1-AS/miR-494-3p Regulates Cell Proliferation, Apoptosis, Migration and Invasion via PTEN/PI3K/AKT Signaling Pathway in Non-Small Cell Lung Cancer.
    Wu C; Yang J; Li R; Lin X; Wu J; Wu J
    Onco Targets Ther; 2021; 14():891-904. PubMed ID: 33603394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding HOXA11-AS knockdown suppresses the progression of non-small cell lung cancer by regulating miR-3619-5p/SALL4 axis.
    Xia H; Niu Q; Ding Y; Zhang Z; Yuan J; Jin W
    J Mol Histol; 2021 Aug; 52(4):729-740. PubMed ID: 34050851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ-AASDH functions as the progression of early stage lung adenocarcinoma by targeting miR-140-3p to activate E2F7 expression.
    Wang Y; Wo Y; Lu T; Sun X; Liu A; Dong Y; Du W; Su W; Huang Z; Jiao W
    Transl Lung Cancer Res; 2021 Jan; 10(1):57-70. PubMed ID: 33569293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.